JP2018526447A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018526447A5 JP2018526447A5 JP2018530940A JP2018530940A JP2018526447A5 JP 2018526447 A5 JP2018526447 A5 JP 2018526447A5 JP 2018530940 A JP2018530940 A JP 2018530940A JP 2018530940 A JP2018530940 A JP 2018530940A JP 2018526447 A5 JP2018526447 A5 JP 2018526447A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- molecular weight
- high molecular
- conditioned medium
- weight complex
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021203331A JP2022027928A (ja) | 2015-09-08 | 2021-12-15 | 細胞拡大培養方法及び治療用組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2015903658 | 2015-09-08 | ||
| AU2015903658A AU2015903658A0 (en) | 2015-09-08 | Cell expansion methods and therapeutic compositions | |
| PCT/AU2016/000316 WO2017041133A1 (en) | 2015-09-08 | 2016-09-08 | Cell expansion methods and therapeutic compositions |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021203331A Division JP2022027928A (ja) | 2015-09-08 | 2021-12-15 | 細胞拡大培養方法及び治療用組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018526447A JP2018526447A (ja) | 2018-09-13 |
| JP2018526447A5 true JP2018526447A5 (enExample) | 2019-10-24 |
| JP6995752B2 JP6995752B2 (ja) | 2022-02-04 |
Family
ID=58240422
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018530940A Expired - Fee Related JP6995752B2 (ja) | 2015-09-08 | 2016-09-08 | 細胞拡大培養方法及び治療用組成物 |
| JP2021203331A Pending JP2022027928A (ja) | 2015-09-08 | 2021-12-15 | 細胞拡大培養方法及び治療用組成物 |
| JP2022172508A Pending JP2022186992A (ja) | 2015-09-08 | 2022-10-27 | 細胞拡大培養方法及び治療用組成物 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021203331A Pending JP2022027928A (ja) | 2015-09-08 | 2021-12-15 | 細胞拡大培養方法及び治療用組成物 |
| JP2022172508A Pending JP2022186992A (ja) | 2015-09-08 | 2022-10-27 | 細胞拡大培養方法及び治療用組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20180236003A1 (enExample) |
| EP (1) | EP3347449A4 (enExample) |
| JP (3) | JP6995752B2 (enExample) |
| KR (1) | KR20180043834A (enExample) |
| CN (1) | CN108348555B (enExample) |
| AU (1) | AU2016321448B2 (enExample) |
| CA (1) | CA3035931A1 (enExample) |
| HK (1) | HK1252778A1 (enExample) |
| TW (1) | TWI760313B (enExample) |
| WO (1) | WO2017041133A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3365432T3 (en) * | 2015-10-23 | 2020-07-27 | Rigshospitalet | Stem cell therapy based on adipose-derived stem cells |
| US12558458B2 (en) | 2017-05-18 | 2026-02-24 | The Board Of Trustees Of The Leland Stanford Junior University | Targeted in situ therapeutic delivery of secreted factors from stem cells for treatment of damaged tissue |
| KR20210021358A (ko) * | 2018-06-15 | 2021-02-25 | 파르도 루이스 마리나스 | 약제학적 피부과 조성물 및 그 용도 |
| CN109022360A (zh) * | 2018-07-03 | 2018-12-18 | 湖南未名三胞转化医学科技有限公司 | 自体脂肪干细胞共培养促进外周血造血干细胞增殖方法 |
| CN110106142B (zh) * | 2019-05-30 | 2020-05-12 | 深圳阿尔法生物科技有限公司 | 一种制备“百亿”级脂肪源再生细胞的生产工艺 |
| CN111073857A (zh) * | 2019-12-30 | 2020-04-28 | 深圳爱生再生医学科技有限公司 | 一种治疗关节炎的干细胞生物制品及其制备方法与应用 |
| KR102193175B1 (ko) * | 2020-04-07 | 2020-12-18 | 주식회사 엑소스템텍 | 통증조절인자를 함유한 줄기세포유래 엑소좀 및 그 용도 |
| CO2020012570A1 (es) | 2020-10-08 | 2022-04-08 | Inst Distrital De Ciencia Biotecnologia E Innovacion En Salud Idcbis | Método de estimulación de células mesenquimales para inducir expresión de factores inmunomoduladores |
| WO2022091086A1 (en) * | 2020-10-26 | 2022-05-05 | Hadasit Medical Research Services And Development Ltd. | Mesenchymal stem cells and their culture |
| US20240352423A1 (en) * | 2021-03-10 | 2024-10-24 | Terasaki Institute For Biomedical Innovation | Methods and systems of producing products such as animal derived products |
| BR102022016233A2 (pt) * | 2022-08-16 | 2024-02-27 | Omics Biotecnologia Animal Ltda | Concentrado de proteínas e peptídeos derivados de células estromais mesenquimais, método de obtenção e uso de concentrado |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0404656D0 (en) * | 2004-03-02 | 2004-04-07 | Univ Manchester | Treatment of spinal conditions |
| US20090305401A1 (en) * | 2006-09-18 | 2009-12-10 | Dirk Strunk | Plasma-free platelet lysate for use as a supplement in cell cultures and for the preparation of cell therapeutics |
| CA2809272A1 (en) * | 2010-08-31 | 2012-03-08 | Cook General Biotechnology Llc | Systemic, allogenic stem cell therapies for treatment of diseases in animals |
| SG10201606745XA (en) | 2011-09-23 | 2016-10-28 | Cell Ideas Pty Ltd | Therapeutics using adipose cells and cell secretions |
| US20140219972A1 (en) | 2013-02-05 | 2014-08-07 | The Board Of Trustees Of The Leland Stanford Junior University | Tissue engineering using progenitor cells to catalyze tissue formation by primary cells |
| ES3042057T3 (en) * | 2016-08-26 | 2025-11-18 | Restem Llc | Composition and methods of using umbilical cord lining stem cells |
-
2016
- 2016-09-08 WO PCT/AU2016/000316 patent/WO2017041133A1/en not_active Ceased
- 2016-09-08 US US15/758,005 patent/US20180236003A1/en not_active Abandoned
- 2016-09-08 KR KR1020187009130A patent/KR20180043834A/ko not_active Ceased
- 2016-09-08 TW TW105129180A patent/TWI760313B/zh not_active IP Right Cessation
- 2016-09-08 EP EP16843295.3A patent/EP3347449A4/en not_active Withdrawn
- 2016-09-08 CN CN201680065321.7A patent/CN108348555B/zh not_active Expired - Fee Related
- 2016-09-08 HK HK18112140.4A patent/HK1252778A1/zh unknown
- 2016-09-08 AU AU2016321448A patent/AU2016321448B2/en not_active Ceased
- 2016-09-08 CA CA3035931A patent/CA3035931A1/en active Pending
- 2016-09-08 JP JP2018530940A patent/JP6995752B2/ja not_active Expired - Fee Related
-
2021
- 2021-02-09 US US17/171,885 patent/US20210260129A1/en not_active Abandoned
- 2021-12-15 JP JP2021203331A patent/JP2022027928A/ja active Pending
-
2022
- 2022-10-27 JP JP2022172508A patent/JP2022186992A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG10201903474PA (en) | New substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said new substituted indazoles, and use of said new substituted indazoles to produce drugs | |
| JP2018009002A5 (enExample) | ||
| JP2017519723A5 (enExample) | ||
| HK1252778A1 (zh) | 细胞扩增方法和治疗组合物 | |
| HRP20240798T1 (hr) | Terapija matičnim stanicama kod patologija endometrija | |
| Wu et al. | c73 new mechanisms and therapies in copd: activating transcription factor 3 represses cigarette smoke-induced il6 and il8 expression via suppressing nuclear factor-κb (nf-κb) activation | |
| JP2016518415A5 (enExample) | ||
| ZHONG et al. | To investigate the treatment and mechanism of Allicin on Behcet′ s disease | |
| YANG et al. | Effect of paroxetine combined with low dose of olanzapine on sleep process and architecture of depression patients with insomnia | |
| CHEN | Efficacy of oral montelukast combined with budesonide suspension inhalation in the treatment of children with cough variant asthma and its effect on inflammatory cytokines | |
| YU | Latest research topics on allergic asthma | |
| MENG et al. | Influence of psychological nursing intervention on the pain, sleep quality and life quality of patients with gastric cancer | |
| WU et al. | Effect of glutamine on p38MAPK and IL-8 expression in PBMC of patients with chronic obstructive pulmonary disease | |
| CN105770384A (zh) | 一种药物组合物提取物及其用途 | |
| PAN et al. | The effects of Xuebijing injection on immune function of patients with acute exacerbation of chronic obstructive pulmonary disease | |
| XU et al. | Effect of Zafirlukast on the inflammatory factors and immune function of patients with seasonal allergic asthma | |
| TONG et al. | Role of Th1 cell and its related cytokines IFN-γin the regulation of immune function in patients with AIDS | |
| XIE et al. | Application of deferred stent implantation in patients with high thrombus burden of acute ST-segment ele-vation myocardial infarction | |
| Dewhurst et al. | C34 INSIGHTS INTO COPD PATHOGENESIS FROM PRE-CLINICAL STUDIES: Characterising Subpopulations Of Alveolar And Interstitial Macrophages In Chronic Obstructive Pulmonary Disease | |
| Jiang et al. | Changes of CD4+ CD25+ Foxp3+ regulatory T cells in different stages of COPD and intervention of Qibai Pingfei Capsules | |
| LIU | The relation between chemokines and retinal vein occlusion | |
| Schlaich et al. | D101 ALLERGY AND ASTHMA: NOVEL REGULATORY PATHWAYS: P2y14 Receptor Deficiency Attenuates Phenotype Of Allergic Airway Inflammation In Mice | |
| Kroll et al. | Risk Mitigation for Hematopoietic Progenitor Cell Infusion-Related Toxicity in Autologous Stem Cell Transplant Recipients | |
| DAI et al. | Nursing progress of fecal bacteria transplantation | |
| CAI et al. | Effect of racecadotril granules combined with montmorillonite on infantile rotavirus enteritis and myocardium enzymogram |